p53 protein expression in pancreatic tumors and its relationship to clinicopathological factors and prognosis

Journal of Surgical Oncology

Volumn 62, Issue 4, 1996, Pages 279-283

  Aizawa, Shunji ^a   Sasaki, Mutsuo ^a   Wada, Ryu Ichi ^a   Koyama, Motoi ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

clinical behavior; immunohistochemistry; pancreatic carcinoma; tumor suppressor oncogene

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GROWTH; CLINICAL OBSERVATION; DIAGNOSTIC VALUE; GENE LOCATION; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029779683     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199608)62:4<279::AID-JSO11>3.0.CO;2-0     Document Type: Article

References (26)

1. Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta 1155:181-205, 1993.
2. Lane DP, Crawford LV: T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263, 1979.
3. Kastan MB, Onyekwere O, Sidransky D et al.: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311, 1991.
4. Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093, 1989.
5. Iggo R, Gatter K, Bartek J, Lane D, et al.: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675-679, 1990.
6. Vogelstein B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal tumor development. N Eng J Med 319:525-532, 1988.
7. Rodrigues NR, Rowan A, Smith MEF, et al.: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559, 1990.
8. Martin HM, Filipe MI, Morris RW, Lane DP, et al.: p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859-862, 1992.
9. Hurlimann J, Saraga EP: Expression of the p53 protein in gastric carcinomas. Assocation with histologic type and prognosis. Am J Surg Pathol 18:1247-1253, 1994.
10. Li ZH, Zheng J, Weiss LM, Shibata D. c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144:303-309, 1994.
11. Furihata M, Inoue K, Ohtsuki Y, et al.: High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53:4823-4827, 1993.
12. Hurlimann J, Chaubert P, Benhattar J: p53 gene alterations and p53 proteins accumulation in infiltrating ductal breast carcinomas: Correlation between immunohistochemical and molecular biology techniques. Mordern Pathol 7:423-428, 1994.
13. Barton CM, Staddon SL, Hughes CM, et al.: Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br J Cancer 64:1076-1082, 1991.
14. Scarpa A, Capelli P, Mukai K, et al.: Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142:1534-1543, 1993.
15. DiGiuseppe Ja, Hruban RH, Goodman SN, et al.: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 101:684-688, 1994.
16. Zhang SY, Ruggeri B, Agarwal P, et al.: Immunohistochemical analysis of p53 expression in human pancreatic carcinomas. Arch Pathol Lab Med 118:150-154, 1994.
17. Boschman CR, Stryker S, Reddy JK, Rao MS: Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol 145:1291-1295, 1994.
18. Hoshi T, Imai M, Ogawa K: Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J Surg Oncol 55:84-91, 1994.
19. Japan Pancreas Society: "General Rules for the Study of Pancreatic Cancer," 4th ed. Tokyo: Kanehara Shuppan, 1993.
20. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748, 1991.
21. Ackerman J, Baunoch DA, Gimotty P, et al.: The role of p53 mutations in bilateral breast carcinoma. Modern Pathol 8:244-248, 1995.
22. Campo E, de la Calle-Martin O, Miquel R, et al.: Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 51:4436-4442, 1991.
23. Merlo GR, Basolo F, Fiore L, et al.: p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 128:1185-1196, 1995.
24. Yoshimoto K: Genetic abnormalities in endocrine pancreatic tumors. J Bil Pane 13:247-251, 1992 (in Japanese).
25. Hoorens A, Lemoine NR, McLellan E, et al.: Pancreatic acinar cell carcinoma: An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 143:685-698, 1993.
26. Momand J, Zambetti GP, Olson DC, et al.: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245, 1992.